Surufatinib Shows Efficacy and Safety in Later-Line Advanced Sarcoma Trial
Advanced sarcoma remains one of oncology’s most difficult treatment challenges, particularly after tumors stop responding to standard chemotherapy, targeted drugs, ...
Advanced sarcoma remains one of oncology’s most difficult treatment challenges, particularly after tumors stop responding to standard chemotherapy, targeted drugs, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine